开发可离子化脂质纳米颗粒和冷化配方,用于强大的CRISPR-Cas9传递和基因组编辑
Qian Sun1, Hongqian Zhang1, Feng Ding1
1Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, and School of Chemistry and Chemical Engineering, Shandong University, Jinan 25010, China.
International journal of pharmaceutics
|January 24, 2024
概括
研究人员开发了用于CRISPR-Cas9传递的新型电离性脂质纳米粒子 (iLNPs). 1A14-iLNP配方显示了基因编辑的高效率和mRNA疗法的潜力.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因编辑技术的技术
背景情况:
- 克里斯普尔-卡斯基因组编辑提供了巨大的生物医学潜力,但需要高效的传递系统.
- 开发有效的CRISPR-Cas组件,如Cas9mRNA和指导RNA (sgRNA) 的传递工具仍然是一个重大挑战.
研究的目的:
- 为了合成和评估新型的可电离性脂质纳米粒子 (iLNPs),用于CRISPR-Cas9mRNA和sgRNA的联合传递.
- 优化iLNP配方,以提高细胞吸收,内体逃生和基因编辑效率.
- 评估领先iLNP候选物的体内传递和生物相容性,并探索冷化以改善配方.
主要方法:
- 通过将烯酸与各种氨基分子结合,合成可离子化脂质.
- 电离性脂质纳米颗粒 (iLNPs) 的组装用于 Cas9 mRNA 和 sgRNA 的联合封装.
- 在体外评估细胞吸收,内体逃生和mRNA表达.
- 对基因编辑效率的评估,针对HeLa-EGFP细胞中的EGFP.
- 针对肝脏向输送和生物相容性评估的体内研究.
- 开发一种由冷化介导的逆转染法.
主要成果:
- 1A14-iLNP配方,利用脂质与精子作为氨基头,在体外表现出优异的细胞吸收,内体逃生和mRNA表达.
- 使用1A14-iLNP同时输送Cas9mRNA和sgRNA,在HeLa-EGFP细胞中达到高达70%的EGFP淘汰效率.
- 在体内研究表明,1A14-iLNP通过良好的生物相容性向肝脏准Cas9mRNA的被动输送.
- 为了高效的CRISPR-Cas9传递,建立了一个简单的冷化中介反转染法.
结论:
- 新的1A14-iLNP配方代表了CRISPR-Cas9传递的高效系统,改善了基因编辑结果.
- 开发的iLNP和冷化技术为推进基于mRNA和CRISPR的治疗应用提供了一个有希望的解决方案.
- 这项工作通过增强的交付策略,促进了CRISPR-Cas技术的更广泛的生物医学应用.
相关概念视频
CRISPR
51.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.0K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


